News Snapshot:
National Medical Products Administration Conditional Approved To Vaccine From Cansino Biologics And One From State-Owned Sinopharm. By HUIZHONG WU The National Medical Products Administration Gave Conditional Approval To A Vaccine From Cansino Biologics And A Second One From State-Owned Sinopharm. Both are already being used among select groups of people under an emergency use authorization. China now has four vaccines to immunize its population. CanSino said its one-shot vaccine candidate is 65.28% effective 28 days after the dose is given. It can be stored at 2 degrees to 8 degrees Celsius, “making it more accessible especially to the regions with...